全球代謝體學市場規模、佔有率、成長分析、按產品和服務、按最終應用分類 - 行業預測，2024-2031 年

Global Metabolomics Market Size, Share, Growth Analysis, By Product and service(Metabolomics Instruments, Separation Tools), By End-use(Academic and Research Institutes, Pharmaceutical & Biotechnology Companies) - Industry Forecast 2024-2031

出版日期: 2024年03月28日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年代謝體學的全球市場規模為28.3億美元，從2023年的32億美元成長到2031年的85.1億美元，預測期內（2024-2031年）複合年成長率為13%，預計也將成長。

慢性病數量的增加、對個人化醫療的需求不斷成長以及技術進步正在促進全球代謝體學市場的穩定成長。代謝體學市場的目標是提供資源和設備，使科學家和醫療專業人員能夠了解生物系統的基本生化過程。透過研究細胞產生的代謝物，科學家可以了解疾病的根源並發現未來潛在的治療標靶。用於疾病診斷和個體化醫療的生物標記的創建是代謝體學的進一步應用。隨著核磁共振波譜和質譜等代謝物分析高通量平台的發展，代謝體學分析變得更快、更準確。由於產生的資料的數量和複雜性，代謝體學資料的解釋可能很困難。慢性病盛行率的上升、對定製藥物治療的需求不斷成長以及技術進步正在推動全球代謝體學市場的發展。市場面臨設備價格高、標準缺失、人才缺乏等挑戰。代謝體學市場有望促進政府、工業界和學術界之間的合作，以創造新的應用。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲

競爭格局

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

Agilent Technologies, Inc.（US）
Thermo Fisher Scientific, Inc.（US）
Shimadzu Corporation（Japan）
Waters Corporation（US）
Bruker Corporation（US）
PerkinElmer, Inc.（US）
Danaher Corporation（US）
Bio-Rad Laboratories, Inc.（US）
Metabolon, Inc.（US）
Human Metabolome Technologies, Inc.（Japan）
Agios Pharmaceuticals, Inc.（US）
LECO Corporation（US）
Biocrates Life Sciences AG（Austria）
Shimazu Europe GmbH（Germany）
Eurofins Scientific（Luxembourg）
Molecular Devices, LLC（US）
Phenomenex, Inc.（US）
Cambridge Isotope Laboratories, Inc.（US）
Sciex（US）
JEOL Ltd.（Japan）

簡介目錄

Product Code: SQMIG35H2164

Global Metabolomics Market size was valued at USD 2.83 Billion in 2022 and is poised to grow from USD 3.20 Billion in 2023 to USD 8.51 Billion by 2031, at a CAGR of 13 % during the forecast period (2024-2031).

The increased prevalence of chronic diseases, the growing need for personalized medication, and technological improvements have all contributed to the steady growth of the worldwide metabolomics market. The goal of the metabolomics market is to give scientists and medical professionals resources and instruments that will enable them to comprehend the fundamental biochemical processes that underlie biological systems. Scientists can learn more about the underlying causes of disease and find possible targets for future treatments by examining the metabolites that cells create. The creation of biomarkers for illness diagnosis and tailored medicine are further uses for metabolomics. Metabolomics analysis is now more faster and more accurate thanks to the development of high-throughput platforms for metabolite profiling, such as nuclear magnetic resonance spectroscopy and mass spectrometry. Because of the volume and complexity of the data generated, metabolomics data interpretation can be difficult. The rising incidence of chronic diseases, the growing need for tailored medication, and technological improvements are driving the worldwide metabolomics market. The market faces difficulties such the high price of instruments, the absence of standards, and the scarcity of qualified workers. There are plenty of prospects in the market for government, business, and academic cooperation as well as for the creation of new applications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Metabolomics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Metabolomics Market Segmental Analysis

The product, application, and geographic segments of the worldwide metabolomics market are divided up. The market is divided into three segments based on the kind of product and service: metabolomics instruments, separation tools, and detection tools. The market is divided into academic and research institutions, pharmaceutical and biotechnology firms, contract research organizations, and others based on the end-use segmentation. The market is divided into five regions: Latin America, Middle East and Africa, Asia Pacific, Europe, and North America.

Drivers of the Global Metabolomics Market

The market has been significantly influenced by the ongoing developments in metabolomics technology, including mass spectrometry, NMR spectroscopy, and data analysis tools. These developments improve metabolomics analysis's sensitivity, accuracy, and throughput, allowing scientists to draw deeper conclusions from metabolomics data.

Restraints in the Global Metabolomics Market

One major obstacle to the market is the high cost of metabolomics devices, consumables, and data analysis tools. The use of metabolomics technology is restricted, especially in environments with limited resources, by the initial cost of setting up metabolomics laboratories and the continuing costs for consumables and maintenance.

Market Trends of the Global Metabolomics Market

Integrating metabolomics data with genomes, proteomics, and transcriptomics data is known as the integration of multi-omics techniques. This integration offers insights into intricate biological processes and the causes of disease, enabling a thorough understanding of biological systems. Systems biology and customized medicine are projected to advance as a result of the integration of multi-omics data.

Application of Metabolomics in Microbiome Research: The study of the metabolic interactions between host organisms and the microbial communities they are linked with is made possible by the growing application of metabolics in microbiome research. Understanding the metabolites generated by the microbiome and how they affect host health and illness is possible through metabolomics. It is anticipated that the use of metabolomics in microbiome research will spur additional advancements in the fields of microbial ecology, tailored nutrition, and gut health.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Metabolomics Market by Product and service

Market Overview
Metabolomics Instruments
Separation Tools
and Detection Tools

Global Metabolomics Market by End-use

Market Overview
Academic and Research Institutes
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
and other End Users

Global Metabolomics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Waters Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Metabolon, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Human Metabolome Technologies, Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agios Pharmaceuticals, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LECO Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocrates Life Sciences AG (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimazu Europe GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Molecular Devices, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Phenomenex, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cambridge Isotope Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sciex (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
JEOL Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments